Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,310Revenue $M503Net Margin (%)11.9Altman Z-Score4.1
Enterprise Value $M1,254EPS $1.0Operating Margin %18.1Piotroski F-Score7
P/E(ttm)34.6Beneish M-Score-2.4Pre-tax Margin (%)17.2Higher ROA y-yY
Price/Book2.210-y EBITDA Growth Rate %4.4Quick Ratio4.4Cash flow > EarningsY
Price/Sales3.55-y EBITDA Growth Rate %1.7Current Ratio5.3Lower Leverage y-yY
Price/Free Cash Flow129y-y EBITDA Growth Rate %34.6ROA % (ttm)6.4Higher Current Ratio y-yY
Dividend Yield %--PEG22.7ROE % (ttm)10.8Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M38.9ROIC % (ttm)11.4Gross Margin Increase y-yY

Gurus Latest Trades with EBS

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
EBSKen Fisher 2015-12-31 Reduce$28.34 - $40.28
($34.97)
$ 33.63-4%Reduce -0.19%457,742
EBSKen Fisher 2015-09-30 Reduce$28.49 - $35.63
($32.99)
$ 33.632%Reduce -0.82%458,634
EBSKen Fisher 2015-06-30 Reduce$28.76 - $33.69
($30.97)
$ 33.639%Reduce -7.78%462,428
EBSJoel Greenblatt 2014-09-30 Sold Out -0.06%$21.31 - $24.9
($22.93)
$ 33.6347%Sold Out0
EBSJoel Greenblatt 2014-03-31 Buy 0.1%$22.85 - $28.09
($25.19)
$ 33.6334%New holding258,760
EBSJohn Rogers 2014-03-31 Sold Out -0.04%$22.85 - $28.09
($25.19)
$ 33.6334%Sold Out0
EBSJohn Rogers 2013-12-31 Add0.02%$17.71 - $23.95
($20.84)
$ 33.6361%Add 105.79%122,650
EBSJohn Rogers 2013-09-30 Add0.01%$15.22 - $19.43
($17.88)
$ 33.6388%Add 116.73%59,600
EBSJohn Rogers 2013-06-30 Buy 0.01%$13.08 - $15.73
($14.48)
$ 33.63132%New holding27,500
EBSJoel Greenblatt 2013-03-31 Sold Out -0.14%$13.95 - $16.9
($15.67)
$ 33.63115%Sold Out0
EBSJoel Greenblatt 2012-12-31 Buy 0.14%$12.91 - $16.09
($14.64)
$ 33.63130%New holding147,099
EBSKen Fisher 2012-12-31 Add$12.91 - $16.09
($14.64)
$ 33.63130%Add 21.09%401,700
EBSJoel Greenblatt 2011-12-31 Sold Out -0.08%$15.43 - $19.64
($17.41)
$ 33.6393%Sold Out0
EBSJoel Greenblatt 2011-06-30 Reduce-0.05%$20.66 - $24.98
($23.2)
$ 33.6345%Reduce -20.74%26,620
EBSKen Fisher 2011-06-30 Add0.01%$20.66 - $24.98
($23.2)
$ 33.6345%Add 160.57%300,305
EBSJoel Greenblatt 2011-03-31 Add0.17%$20.64 - $24.55
($22.62)
$ 33.6349%Add 243.58%33,585
EBSKen Fisher 2011-03-31 Buy 0.01%$20.64 - $24.55
($22.62)
$ 33.6349%New holding115,250
EBSJoel Greenblatt 2010-12-31 Buy 0.07%$17.59 - $23.8
($19.23)
$ 33.6375%New holding9,775
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

EBS is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


EBS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Bailey SueDirector 2016-01-04Sell11,520$38.79-13.3view
Richard RonaldDirector 2015-12-30Sell21,600$40-15.93view
Abdun-Nabi DanielPresident & CEO 2015-12-24Sell63,209$39.06-13.9view
El-Hibri FuadChairman, 10% Owner 2015-11-19Sell17,871$37.5-10.32view
El-Hibri FuadChairman, 10% Owner 2015-11-13Sell13,013$36.5-7.86view
Labinger BarryEVP, Biosciences Div. 2015-11-13Sell3,376$36.5-7.86view
Labinger BarryEVP, Biosciences Div. 2015-11-12Sell36,126$35.64-5.64view
El-Hibri FuadChairman, 10% Owner 2015-11-09Sell13,225$35.5-5.27view
El-Hibri FuadChairman, 10% Owner 2015-11-06Sell13,450$34.5-2.52view
El-Hibri FuadChairman, 10% Owner 2015-11-03Sell13,689$33.50.39view

Press Releases about EBS :

Quarterly/Annual Reports about EBS:

News about EBS:

Articles On GuruFocus.com
Weekly CEO Sales Highlight: Realpage, Anadigics, Emergent BioSolutions, ScanSource Jan 03 2016 
Emergent BioSolutions Inc. Reports Operating Results (10-Q) Nov 05 2010 
Emergent BioSolutions Inc. Reports Operating Results (10-Q) Aug 06 2010 
Emergent BioSolutions Inc. (EBS) President & COO Daniel Abdun-nabi sells 18,150 Shares Jul 30 2010 
Weekly CEO Sells Highlight: Yum! Brands Inc, Marchex Inc, iGate Corp, and Emergent BioSolutions Inc. Jul 25 2010 
Emergent BioSolutions Inc. (EBS) CEO and Chairman, 10% Owner Fuad El-hibri sells 18,800 Shares Jul 23 2010 
Emergent BioSolutions Inc. (EBS) CEO and Chairman, 10% Owner Fuad El-hibri sells 130,100 Shares Jul 22 2010 
Emergent BioSolutions Inc. (EBS) CEO and Chairman, 10% Owner Fuad El-hibri sells 84,433 Shares Jul 19 2010 
Emergent BioSolutions Inc. (EBS) CEO and Chairman, 10% Owner Fuad El-hibri sells 52,000 Shares May 14 2010 
Emergent BioSolutions Inc. Reports Operating Results (10-Q) May 06 2010 

More From Other Websites
Odd Bedfellows Emerge In The IBD 50 Feb 05 2016
Emergent BioSolutions, Inc. – Value Analysis (NYSE:EBS) : February 3, 2016 Feb 03 2016
Emergent BioSolutions, Inc. breached its 50 day moving average in a Bullish Manner : February 3,... Feb 03 2016
As Zika virus spreads, these Greater Washington companies are trying to stop it Jan 28 2016
Emergent BioSolutions Announces Executive Management Team of New Spin-Off Company Aptevo... Jan 21 2016
Emergent BioSolutions Announces Executive Management Team of New Spin-Off Company Aptevo... Jan 21 2016
Ligand, Emergent BioSolutions Tie Up for OmniAb Technology Jan 14 2016
Emergent Biosolutions Releases Preliminary 2015 Results, 2016 Outlook And Strategic Growth Plan... Jan 11 2016
Emergent Biosolutions Announces Preliminary 2015 Financial Results, Provides 2016 Financial Outlook,... Jan 11 2016
EMERGENT BIOSOLUTIONS INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Jan 11 2016
Emergent Biosolutions Announces Preliminary 2015 Financial Results, Provides 2016 Financial Outlook,... Jan 11 2016
Emergent BioSolutions Receives Favorable IRS Private Letter Ruling in Connection With its Planned... Jan 10 2016
Emergent BioSolutions Receives Favorable IRS Private Letter Ruling in Connection With its Planned... Jan 10 2016
Emergent BioSolutions, Inc. breached its 50 day moving average in a Bearish Manner : January 8, 2016 Jan 08 2016
EMERGENT BIOSOLUTIONS INC. Files SEC form 8-K, Change in Directors or Principal Officers Jan 04 2016
Weekly CEO Sales Highlight: Realpage, Anadigics, Emergent BioSolutions, ScanSource Jan 03 2016
22.12.2015 - Outlook for Stock Markets and the Vienna Stock Exchange Dec 23 2015
Maryland company to spin out new publicly traded Seattle cancer biotech Dec 22 2015
EMERGENT BIOSOLUTIONS INC. Files SEC form 8-K, Change in Directors or Principal Officers Dec 22 2015
Emergent BioSolutions Announces Composition of Board of Directors of New Spin-Off Company Aptevo... Dec 22 2015

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK